At Kailera, we are bold, authentic and committed to our mission of developing therapies that give people the power to transform their lives and elevate their overall health. Rooted in an entrepreneurial spirit and a team-oriented culture, we are working together to advance Kailera’s mission to advance novel therapies for obesity and related conditions.
We are passionate about creating an inclusive workplace that promotes collaboration, integrity, and excellence. As we expand, we seek the most talented individuals with diverse backgrounds, cultures, perspectives, and experiences to join our team.
What You’ll Do:
The Senior Specialist, GMP Quality Assurance will collaborate internally with QA, RA, and CMC departments. As needed, work with external Approved Service Providers to ensure oversight and compliance. The Senior Specialist will perform review of drug substance/drug product manufacturing records and associated documents (i.e. deviations) for product that will be released for use in Kailera phase I-III clinical programs. The Senior Specialist will help continuously improve Quality System Procedures related to GMP activities related to their function and will collaborate closely with internal cross-functional teams.
Required location: Waltham, MA (hub-based, onsite 3-4 days per week)
Responsibilities:
- Review and approve Service Provider GMP documentation
- Review and approve master batch/packaging records
- Review executed batch/packaging records for Intermediates, Drug Substance, and Drug Product
- Prepare batch file for final batch disposition for Kailera’s Phase I-III clinical programs
- Review GMP Quality Events, change controls, CAPA’s, and other GMP documentation as needed
- Identify and escalate issues effectively
- Compile data for Quality System Reviews
- Evaluate GMP activities for continuous improvement opportunities
- Support creation and continuous improvement of Kailera procedures
- Other Quality Assurance responsibilities as assigned
Required Qualifications:
- 6+ years of experience in an FDA regulated Pharmaceutical Industry with GMP experience
- Understanding and knowledge of industry standards, concepts, current cGMP (21 CFR Parts 210 & 211 & Part 11 and EudraLex), and other agency standards and guidance as they relate to quality systems/quality assurance
- Experience with review of GMP manufacturing/packing records (Master/Executed Batch Records, Deviations, Change Controls, etc.) associated with Phase I-III clinical studies
- Proficient in Veeva QualityDocs and Veeva QMS a plus
- Demonstrates proven track record of communication with internal and external Service providers
- Ability to identify quality issues requiring escalation
- Clear, concise writing skills and good verbal presentation skills
- Self-motivated, detail oriented, well organized, and able to manage multiple projects
- Ability to interact constructively and efficiently with co-workers within and across departments and Management, as well as with Service providers in a professional and collaborative manner
Preferred Qualifications:
- Biotech experience preferred
Education:
- BA or BS degree in a scientific discipline or supplemental Quality education
For Full Time Roles: This range represents the company’s good-faith estimate of the salary at the time of posting. Actual pay may vary based on experience, skills, qualifications, location, and internal equity. We also offer comprehensive health coverage, flexible time off, paid holidays, and a year-end shutdown. Enjoy a monthly wellness stipend, generous 401(k) match, tuition reimbursement, commuter benefits, disability and life insurance, plus annual bonus opportunities and equity grants—because your well-being and future matter to us.
EQUAL EMPLOYMENT OPPORTUNITY INFORMATION:
Kailera Therapeutics, Inc. is an Equal Opportunity Employer that does not discriminate on the basis of actual or perceived race (including traits historically associated with race, such as hair texture and protective hairstyles), color, creed, religion (including religious dress and grooming practices), national origin, ancestry, citizenship status, age (40 and over), sex or gender (including pregnancy, childbirth, pregnancy-related conditions, and lactation), gender identity or expression (including transgender status), sexual orientation, marital status, military service and veteran status, physical or mental disability, genetic information, reproductive health decisions, domestic victim status, political affiliation, or any other characteristic protected by applicable federal, state, or local laws and ordinances.
E-Verify:
Kailera Therapeutics, Inc. uses E-Verify to confirm the identity and employment eligibility of all new hires.
#LI-Hybrid
Skills Required
- 6+ years of experience in an FDA-regulated pharmaceutical industry with GMP experience
- Knowledge of industry standards, current cGMP requirements, 21 CFR Parts 210, 211, and 11, EudraLex, and agency guidance related to quality systems and quality assurance
- Experience reviewing GMP manufacturing and packaging records, deviations, change controls, and related documentation for Phase I-III clinical studies
- Proficient in Veeva QualityDocs and Veeva QMS
- Proven communication experience with internal and external service providers
- Ability to identify quality issues requiring escalation
- Clear, concise writing and verbal presentation skills
- Self-motivated, detail-oriented, well-organized, and able to manage multiple projects
- Ability to collaborate professionally with coworkers, management, cross-functional departments, and service providers
- BA or BS degree in a scientific discipline or supplemental quality education
- Biotech experience
What We Do
Kailera is an advanced clinical-stage biotechnology company focused on obesity care. It is developing a diversified pipeline of GLP-1 therapies and other obesity-management medications intended to provide treatment options for people living with obesity across their treatment journeys. The company’s team has experience developing and commercializing therapies for metabolic diseases, and its clinical-stage candidates use multiple GLP-1 mechanisms and routes of administration.
